|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 August 2002, Vol. 100, No. 4, pp. 1294-1301
HEMATOPOIESIS
Kit signaling inhibits the sphingomyelin-ceramide pathway through
PLC 1: implication in stem cell factor radioprotective
effect
Stéphane Maddens,
Alexandra Charruyer,
Isabelle Plo,
Patrice Dubreuil,
Stuart Berger,
Bernard Salles,
Guy Laurent, and
Jean-Pierre Jaffrézou
From the Institut Nationale de la Santé et de la
Recherche Médicale E9910, Institut Claudius Régaud,
Institut de Pharmacologie et de Biologie Structurale, Service
d'Hématologie, and Centre Hospitalier Universitaire Purpan,
Toulouse, France; Laboratoire de Cancérologie
Expérimentale, Institut National de la Santé et de la
Recherche Médicale U119, Institut Paoli Calmettes, Marseille,
France; and Arthritis and Immune Disorder Research Centre, Toronto,
Ontario, Canada.
Previous studies demonstrated that Kit activation confers
radioprotection. However, the mechanism by which Kit signaling
interferes with cellular response to ionizing radiation (IR) has not
been firmly established. Based on the role of the sphingomyelin (SM) cycle apoptotic pathway in IR-induced apoptosis, we hypothesized that
one of the Kit signaling components might inhibit IR-induced ceramide
production or ceramide-induced apoptosis. Results show that, in both
Ba/F3 and 32D murine cell lines transfected with wild-type c-kit, stem
cell factor (SCF) stimulation resulted in a significant reduction of
IR-induced apoptosis and cytotoxicity, whereas DNA repair remained
unaffected. Moreover, SCF stimulation inhibited IR-induced neutral
sphingomyelinase (N-SMase) stimulation and ceramide production. The SCF
inhibitory effect on SM cycle was not influenced by wortmannin, a
phosphoinositide-3 kinase (PI3K) inhibitor. The SCF protective effect
was maintained in 32D-KitYF719 cells in which the PI3K/Akt signaling
pathway is abolished due to mutation in Kit docking site for PI3K. In
contrast, phospholipase C (PLC ) inhibition by U73122 totally
restored IR-induced N-SMase stimulation, ceramide production, and
apoptosis in Kit-activated cells. Moreover, SCF did not protect
32D-KitYF728 cells (lacking a functional docking site for PLC 1),
from IR-induced SM cycle. Finally, SCF-induced radioprotection of human
CD34+ bone marrow cells was also inhibited by U73122.
Altogether, these results suggest that SCF radioprotection is due to
PLC 1-dependent negative regulation of IR-induced N-SMase
stimulation. Beyond the scope of Kit-expressing cells, it suggests that
PLC 1 status could greatly influence the post-DNA damage cellular
response to IR, and perhaps, to other genotoxic agents.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Lennartsson, T. Jelacic, D. Linnekin, and R. Shivakrupa
Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit
Stem Cells,
January 1, 2005;
23(1):
16 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Hong, V. Munugalavadla, and R. Kapur
c-Kit-Mediated Overlapping and Unique Functional and Biochemical Outcomes via Diverse Signaling Pathways
Mol. Cell. Biol.,
February 1, 2004;
24(3):
1401 - 1410.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |